I know the market doesn’t seem to care atm, but I think we are in a better position than yesterday. It just reinforces in my mind that Cynata’s decision to do a rct in HR-agvhd is the right approach.
Furthermore, we are almost at a recruitment stage with 30 sites activating.
The trial is somewhat risky as it will be measuring efficacy of Cynata mscs against steroids (essentially SOC), but I guess that’s what you have to prove to be taken seriously anyway.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $44.06M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 19.5¢ | 17.5¢ | $31.74K | 167.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12000 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 160434 | 1 |
View Market Depth
| Last trade - 11.55am 12/08/2025 (20 minute delay) ? |
| CYP (ASX) Chart |